Cancer Vaccines Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer
Conditions: Neoplasms; Esophageal Neoplasms; Esophagus Neoplasm; Esophagus Cancer; Neoplasms, Esophageal; Esophageal Cancer (EsC) Interventions: Drug: Nivolumab; Drug: Entinostat; Biological: Montanide(R) ISA-51 VG Adjuvant; Biological: H1299 Cell Lysates Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials

TEIPP Immunotherapy in Patients With NSCLC
Condition: Non Small Cell Lung Cancer Intervention: Drug: TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51) Sponsor: Erasmus Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials